US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively, compared with 20231FY 2024 TRELEGY Net Sales, as ...

The trial aims to evaluate the therapy’s tolerability, pharmacokinetics and safety in around 56 healthy volunteers.

French biotech tart-up EG 427 has successfully closed a 27 million-euro ($28.4 million) Series B financing round co-led by ...

CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to ...

Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...

EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical ...

Robert David The so-called ‘free market’ was never free—it’s a stage-managed spectacle where financial elites dictate the ...

Discover the powerful herbs and vitamins that support neurogenesis and neuroprotection, promoting brain health and resilience ...

IT can feel like you’re being repeatedly kicked down when your partner turns down your sexual advances. Rejection stings ...

Botox is derived from botulinum toxin type A, a toxin that’s produced from the bacterium Clostridium botulinum. It just so happens to be the same bacterium that causes botulism, a rare condition that ...

The aim of this study was to assess the feasibility of a bowel management program for patients with neurogenic bowel function after spinal cord injury. The program is based on evidence-based nursing, ...